We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Baxter Intnl. | LSE:BAX | London | Ordinary Share | COM STK $1 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:7116R Baxter International Inc 5 November 2003 BAXTER INTERNATIONAL NAMES CORPORATE VICE PRESIDENT OF GLOBAL QUALITY MANAGEMENT DEERFIELD, III November 4, 2003 -- Baxter International Inc. (NYSE: BAX) today announced that its board of directors has elected Lawrence T. Gibbons to the corporate officer position of corporate vice president - global quality management. Gibbons, 52, Joins Baxter from Tyco Healthcare, where he served as vice president of quality assurance and regulatory affairs. Gibbons will report to Baxter's chairman and chief executive officer and will be responsible for leading the quality function and overseeing the Implementation of the company's various quality programs. "Larry brings with him a wealth of experience and proven track record in implementing broad quality Initiatives and systems across large organizations. He will play a significant role in leading our quality organization in assuring alignment with product integrity goals and in driving continuous process improvement across our global operations," said Harry M. Jansen Kraemer, Jr, chairman and chief executive officer. Gibbons spent more than 20 years in various quality and regulatory positions with increasing responsibility at Kendall Company, which was acquired by Tyco Healthcare in 1994. Prior to joining Kendall Company, Gibbons was an investigator with the U.S. Food and Drug Administration's Boston District Office. Gibbons received his bachelor's degree in science from the University of Massachusetts, Baxter International Inc., through its subsidiaries, assists health-care professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, Immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. FOR ADDITIONAL INFORMATION: Media Contacts: Deborah Spak, 847-948-2349 Elizabeth Shea, 847-948-3297 This information is provided by RNS The company news service from the London Stock Exchange END MSCUVOURORRARAA
1 Year Baxter Intnl. Chart |
1 Month Baxter Intnl. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions